About Us
Asia Air WatchLive PM2.5 Medical Alerts
Research Watch
•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs

Trends in Lyme disease incidence in England, 2013 to 2024.

Researchers

Janie Olver, Mark Gideon Burdon, Eva Emanuel, Ali Datoo, Verena FermorDunman, Miranda Ferguson, Jessica I'Anson, Roberto Vivancos, Christina Petridou, Amanda Semper

Abstract

Official Lyme disease incidence figures for England are based on the number of cases with a laboratory-confirmed diagnosis from the national reference laboratory. However, these figures underestimate the true incidence of acute cases since patients can also be diagnosed clinically without the need for laboratory testing. The use of a multiplication factor has been proposed to estimate total Lyme disease incidence from the number of laboratory-confirmed cases. The current multiplication factor is derived from data spanning 1998-2016 and is thought to be outdated, in part due to the introduction of new national Lyme disease management guidance in 2018. The aim of this study was to analyse more recent laboratory and primary care data to identify trends in case numbers and to derive updated estimates of the total annual number of acute Lyme disease cases in England. Data spanning 2013-2024 from the national reference laboratory and a primary care data source were analysed using seasonal time series models. The presence of structural breaks was investigated using the PELT or BinSeg methods, and annual multiplication factors were estimated using a Poisson regression model. No substantial change was found in the number of laboratory-confirmed Lyme cases from 2013 to 2024 in England, whereas the number of cases diagnosed in primary care increased significantly over the same period, with an average of an additional 498 cases per year. This has increased our best estimate of the multiplication factor from 2.35 (95% confidence interval, 1.81-2.88) to 6.20 (6.17-6.24), which is the average for the years 2020-2024. Use of this updated multiplication factor should improve the accuracy of annual symptomatic Lyme disease case estimates for England.
Source: PubMed (PMID: 43038216)View Original on PubMed